Literature DB >> 32602497

Influence of cyclic and acyclic cucurbiturils on the degradation pathways of the chemical warfare agent VX.

Beatrice Andrae1, Daniel Bauer1, Patrick Gaß1, Marianne Koller2, Franz Worek2, Stefan Kubik1.   

Abstract

The highly toxic nerve agent VX is a methylphosphonothioate that degrades via three pathways in aqueous solution, namely through the hydrolysis of the P-O or P-S bonds, or the cleavage of the C-S bond at the 2-aminoethyl residue. In the latter case, an aziridinium ion and a phosphonothioate is formed. Here it is shown that acyclic or cyclic cucurbiturils inhibit these reactions in phosphate buffer at physiological pH and thus stabilise the nerve agent. When using unbuffered basic solutions as the reaction medium, however, in which the P-S or P-O bonds are normally hydrolysed preferentially, cucurbiturils turned out to strongly shift VX degradation towards the cleavage of the C-S bond. Cucurbit[7]uril, in particular, has a so pronounced effect under suitable conditions that it almost completely suppresses the formation of products resulting from the other degradation pathways. Investigations involving VX analogues in combination with computational methods suggest that one reason for the reaction control exerted by the cucurbiturils is the preorganisation of VX for aziridinium ion formation. In addition, cucurbit[7]uril also lowers the transition state of the reaction by stabilising the positive charge developing on the way to the product. Cucurbiturils thus have a marked effect on the reactivity of a highly toxic nerve agent, which potentially allows using them for decontamination purposes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32602497     DOI: 10.1039/d0ob01167c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  1 in total

Review 1.  Supramolecular hosts as in vivo sequestration agents for pharmaceuticals and toxins.

Authors:  Chun-Lin Deng; Steven L Murkli; Lyle D Isaacs
Journal:  Chem Soc Rev       Date:  2020-10-12       Impact factor: 54.564

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.